For practitioner dispensing and professionally guided use.
Always read the label and follow the directions for use.
Withania products may cause sudden and potentially severe gastrointestinal reactions in some people.
Severe nausea, vomiting or diarrhoea has occasionally occurred after only one or two doses and has sometimes required hospital treatment.
Stop taking the product and seek medical assessment if sudden vomiting, severe diarrhoea, marked abdominal pain or another significant digestive reaction develops.
Medicines and supplements containing Withania have been associated with a very rare risk of liver injury.
Avoid Withania if you currently have or have previously had liver problems unless its use has been specifically assessed and approved by the healthcare professional managing your condition.
Stop use and seek immediate medical advice if yellowing of the skin or eyes, dark urine, nausea, vomiting, unusual tiredness, weakness, abdominal pain or loss of appetite develops.
Do not use Withania to treat abnormal liver-function results, fatty liver disease, hepatitis or another liver condition.
Avoid use during pregnancy.
Do not use while breastfeeding unless specifically directed by an appropriately qualified healthcare professional who has assessed the potential risks and benefits.
Withania is not recommended for people with thyroid disorders unless its use has been approved and monitored by the healthcare professional managing the condition.
Consult your doctor or pharmacist before combining it with levothyroxine, carbimazole, propylthiouracil or another thyroid medicine.
Do not use Withania as a substitute for thyroid blood testing or prescribed thyroid treatment.
Seek assessment for unexplained palpitations, tremor, sweating, heat intolerance, unusual weight change, marked fatigue or neck swelling.
People with autoimmune disease should obtain medical approval before use.
Professional guidance is particularly important with rheumatoid arthritis, lupus, multiple sclerosis, autoimmune thyroid disease, inflammatory bowel disease or another immune-mediated condition.
Do not use without specialist approval if you take immunosuppressive or antirejection medication.
Withania may cause drowsiness and may increase the effects of sedating substances.
Consult your doctor or pharmacist before combining it with sleeping tablets, benzodiazepines, sedating antihistamines, opioid pain medicines, anticonvulsants or other medicines that reduce alertness.
Avoid or limit alcohol and use caution when combining Withania with Valerian, Passionflower, Kava, Lemon Balm or multi-ingredient sleep formulas.
Withania may influence blood glucose or blood pressure.
Professional advice is required for people taking diabetes medicines, insulin, blood-pressure medicines or treatment for cardiovascular disease.
Stop use and seek advice if dizziness, faintness, sweating, trembling, unusual weakness or symptoms of low blood glucose or low blood pressure develop.
Withania should not be described as a treatment for anxiety disorders, depression, panic attacks, chronic insomnia or another mental-health condition.
Persistent anxiety, major changes in mood, loss of interest, severe agitation or symptoms affecting work, study, relationships or daily life require professional support.
Thoughts of self-harm or suicide require immediate assistance from an emergency or crisis service.
Do not describe Withania as increasing testosterone, treating erectile dysfunction or improving fertility.
Limited research has examined particular Ashwagandha extracts for testosterone and sperm parameters, but the evidence should not be applied broadly to every product.
People with hormone-sensitive prostate cancer should avoid Withania unless its use has been specifically approved by the treating specialist.
Persistent fatigue should not automatically be attributed to stress.
Ongoing tiredness may be associated with inadequate sleep, nutrient deficiency, thyroid dysfunction, infection, medication effects, sleep apnoea, depression, heart or lung disease or another health concern.
Available safety information primarily relates to short-term use. Do not continue Withania indefinitely without professional review.
The current product provides an adult dosage only.
Do not give this concentrated 45% ethanol practitioner preparation to a child or adolescent unless an age-appropriate amount has been individually prescribed.
Discontinue use at least seven days before general anaesthesia, surgery, dental surgery or another invasive procedure unless otherwise directed by the treating medical team.
Tell the surgeon, anaesthetist, dentist and pharmacist that Withania has been used.
Contains ethanol.
Keep out of reach of children.